(133 days)
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner.
Powder Free Latex Patient Examination Glove with Protein Content Labeling Claim (Contains 50 Micrograms per dm2 of glove or Less of Water Extractable Protein) meets all the current specification for ASTM D3578-05 (2010).
Here's an analysis of the provided text regarding the acceptance criteria and study for the device, organized as requested:
Device: Powder Free Latex Patient Examination Glove with Protein Content Labeling Claim (Contains 50 Micrograms per dm² of glove or Less of Water Extractable Protein)
1. Table of Acceptance Criteria and Reported Device Performance
| Characteristic | Acceptance Criteria (Standards) | Reported Device Performance |
|---|---|---|
| Dimensions | ASTM D 3578-05 (2010) | Meets |
| Physical Properties | ASTM D 3578-05 (2010) | Meets |
| Freedom from pin-holes | ASTM D 5151-99 (2006) & ASTM D 3578-05 (2010) | Meets |
| Powder Free Residue | ASTM D 6124-06 & ASTM D 3578-05 (2010) | Meets |
| Protein Content | ASTM D 5712-10 & ASTM D 3578-05 (2010) (Specifically: Contains 50 Micrograms/dm² or Less) | Meets |
| Biocompatibility: Dermal Sensitization | ISO 10993-10:2010 | Not a contact skin sensitizer |
| Biocompatibility: Primary Skin Irritation Test | ISO 10993-10:2010 | Not a primary skin irritant |
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state the sample sizes used for the specific tests (e.g., freedom from pin-holes, protein content). It only refers to compliance with the ASTM and ISO standards, which would implicitly define sample sizes for those tests. The data provenance is not specified beyond indicating that Top Calibre Sdn Bhd, a Malaysian company, submitted the information. It is a retrospective compilation of compliance to existing standards rather than a prospective clinical trial.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts
Not applicable. The ground truth for this device is based on adherence to established international and national standards (ASTM, ISO) for medical gloves. This does not involve expert consensus on an "image" or "diagnosis" but rather laboratory and performance testing against objective criteria defined by these standards.
4. Adjudication Method for the Test Set
Not applicable. As the device's performance is measured against objective, published standards, there would be no "adjudication" in the sense of reconciling differing expert opinions. The tests conducted according to the standards would yield measurable results that either meet or do not meet the specified criteria.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done
No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. This type of study is typically associated with diagnostic imaging or clinical decision support AI, where human performance is evaluated with and without AI assistance. This device is a physical examination glove, and its effectiveness is determined by its physical properties and biocompatibility, not by assisting human readers in interpreting clinical data.
6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done
Yes, the testing described appears to be standalone in the sense that the device itself (the glove) was subjected to laboratory tests and its performance was measured against predefined standards without direct human-in-the-loop performance evaluation in a clinical setting for primary efficacy. The performance metrics are objective physical and chemical properties.
7. Type of Ground Truth Used
The ground truth used is based on established national and international standards for medical gloves. This includes:
- Physical properties defined by ASTM D 3578-05 (2010)
- Freedom from pin-holes defined by ASTM D 5151-99 (2006)
- Powder-free residue defined by ASTM D 6124-06
- Protein content defined by ASTM D 5712-10
- Biocompatibility (dermal sensitization and primary skin irritation) defined by ISO 10993-10:2010
8. Sample Size for the Training Set
Not applicable. This device is an examination glove, not an AI/ML algorithm. Therefore, there is no "training set" in the context of machine learning. The manufacturing process of the gloves would be subject to quality control, but this is distinct from an algorithm's training data.
9. How the Ground Truth for the Training Set Was Established
Not applicable, as there is no training set for this device.
{0}------------------------------------------------
TOP CALIBRE SDN. BHD.
JAN 1 8 2012
:
:
FDA 510(k), Premarket Notification: 510(k) Summary of Safety and Effectiveness Information
Date: 02 September 2011
1.0 Submitter:
Top Calibre Sdn Bhd 1-1, 2, Jalan Setia Prima U13/S Setia Alam, Seksyen U13, 40170 Shah Alam, Selangor, Malaysia
+603 3291 0516 Telephone No .: Fax No .: +603 3291 0542
2.0 Contact Person:
| Contact: | Ms Tracy Ngui | |
|---|---|---|
| Telephone No.: | +603 3291 0516 | |
| Fax No.:+603 3291 0542 |
3.0 . Name of Device:
Trade Name: Powder Free Latex Patient Examination Glove with Protein Content Labeling Claim (Contains 50 Micrograms per dm- of glove or Less of Water Extractable Protein)
Patient Examination Glove Common Name: Classification Name: Patient Examination Glove
Identification of the Legally Marketed Device: 4.0
Powder Free Latex Patient Examination Glove with Protein Content Labeling Claim (Contains 50 Micrograms per dm2 of glove or Less of Water Extractable Protein), Class I patient examination gloves, Latex - 80L YY, meets all of the requirements of ASTM D3578-05 (2010) Standard Specification for Rubber Examination Glove.
Predicate Device: K092492, Powder Free Polymer Coated Latex Examination Glove, Non-Sterile, With Protein Labeling Claim of 50 Micrograms per dm- of glove or Less of Water Soluble Protein.
{1}------------------------------------------------
TOP CALIBRE SDN. BHD.
5.0 Description of Device:
Powder Free Latex Patient Examination Glove with Protein Content Labeling Claim (Contains 50 Micrograms per dm2 of glove or Less of Water Extractable Protein) meets all the current specification for ASTM D3578-05 (2010).
6.0 Intended Use of the Device:
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner.
Summary of the Technological Characteristics of the Device: 7.0 .
Powder Free Latex Patient Examination Glove with Protein Content Labeling Claim (Contains 50 Micrograms per dm2 of glove or Less of Water Extractable Protein) possesses the following technological characteristic (as compared to ASTM or equivalent standards):
| Characteristic | Standards | Device Performance |
|---|---|---|
| Dimensions | ASTM D 3578-05(2010) | Meets |
| Physical Properties | ASTM D 3578-05(2010) | Meets |
| Freedom from pin-holes | ASTM D 5151-99(2006)ASTM D 3578-05(2010) | Meets |
| Powder Free Residue | ASTM D 6124-06ASTM D 3578-05(2010) | Meets |
| Protein Content | ASTM D 5712-10ASTM D 3578-05(2010) | Meets |
| Biocompatibility | Dermal Sensitization(as ISO 10993-10:2010)Primary SkinIrritation Test(as ISO 10993-10:2010) | Not a contact skin sensitizerNot a primary skin irritant |
{2}------------------------------------------------
TOP CALIBRE SDN. BHD.
Substantial Equivalent Based on Assessment of Non-Clinical Performance 8.0 Data
The performance test data that support a determination of substantial equivalence are described above.
Substantial Equivalent Based on Assessment of Clinical Performance Data 9.0
Clinical data is not needed for market cleared examination gloves.
10.0 Conclusion
It can be concluded that the Powder Free Latex Patient Examination Glove with Protein Content Labeling Claim (Contains 50 Micrograms per dm2 of glove or Less of Water Extractable Protein), is safe and effective for use with chemotherapeutic agents and will perform according to the glove performance standards referenced in Section 7.0 above, thereby meeting ASTM standards, FDA requirements, and the labeling claims for the product.
Consequently, this device is substantially equivalent to current marketed devices. This summary will include any other information reasonably deemed necessary by the FDA.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, and three wavy lines below it. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
JAN 1 8 2012
Ms. Tracy Ngui QA Manager Top Calibre Sdn Bhd 1-1, 2, Jalan Setia Prima U13/S Setia Alam, Seksyen U13, Shah Alam, Selangor MALAYSIA 40170
Re: K112612
Trade/Device Name: Powder Free Latex Examination Glove With Protein Content Labeling Claim (Contains 50 Micrograms per dm2 of glove or Less of Water Extractable Protein)
Regulation Number: 21 CFR 880.6250
Regulation Name: Patient Examination Glove
Regulatory Class: I
Product Code: LYY
Dated: December 21, 2011
Received: December 27, 2011
Dear Ms. Ngui:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{4}------------------------------------------------
Page 2 - Ms. Ngui
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Anthony D. awat
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
Indications for Use
510(k) Number (if known):
Powder Free Latex Patient Examination Glove With Protein Content Labeling Claim Device Name: (Contains 50 Micrograms per dm2 of glove or Less of Water Extractable Protein)
Indications for Use:
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office Of Device Evaluation (ODE)
Elishth F. Clamin-William
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: KI
| Page 1 of | |
|---|---|
| ----------- | -- |
x
..
§ 880.6250 Non-powdered patient examination glove.
(a)
Identification. A non-powdered patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. A non-powdered patient examination glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.(b)
Classification. Class I (general controls). The device, when it is a finger cot, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 880.9.